Guggenheim raises Roivant Sciences price target to $46 from $42
Guggenheim raised its price target for Roivant Sciences to $46.00 from $42.00 and maintained a Buy rating, per Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.